NSE close · Thu, 1 OctNifty 5022,421.95▼ 0.88%Nifty Bank54,450.75▼ 0.33%Midcap 10058,732.00▼ 1.01%Smallcap 25017,589.05▼ 1.18%India VIX14.46▲ 7.19%IT28,304.70▲ 2.17%Auto25,384.95▼ 3.46%Pharma26,311.55▼ 0.48%FMCG43,789.85▼ 1.61%Metal12,460.70▼ 2.35%Realty835.00▼ 1.46%Energy36,388.15▼ 0.68%PSU Bank7,937.80▼ 0.98%Financials24,556.10▼ 0.38%Media1,546.30▼ 2.33%Defence9,142.55▼ 1.45%Durables35,927.80▼ 1.91%Biggest movesMONEYVIEW▲ 58.5%MOLBIO▲ 15.6%THOMASCOTT▲ 12.3%AUGMONT▲ 10.0%HEROMOTORS▲ 10.0%VIVIANA▲ 10.0%LOKESHMACH▲ 9.5%ANAWIL▼ 11.0%

Top stories

Expansion + Pharma and healthcare · 3 storiesClear filters

Developing 83 Picking up 4 Price moves 3 Following

Busiest tags today

AI80 Bond yields60 Crude oil57 Geopolitics54 Banks44 Global markets42 Trade and tariffs39 Inflation35 US jobs data34 Jobs and layoffs32 US Treasuries31 Autos30 RBI25 Donald Trump25 Every tag in Market pulse →

Topic

Pharma and healthcare▼ −30% net tone today

13 stories today · 190 since 24 SeptNifty Pharma −0.48% vs Nifty −0.88% on Thu, 1 Oct

Granules India incorporated Triton Farmaceutica Do Brasil Ltda as a wholly owned subsidiary in Brazil
Global Health acquired land in Ghaziabad for a planned Medanta hospital
Maharashtra FDA cancelled Cipla Pharma’s Pune warehouse distribution licences over serious violations

Often with, this weekHospitals39 Apollo Hospitals16 Sun Pharma12 USFDA11 Supreme Court9

Open tag page →Clear ×

Stories per day

527 Sept

3528 Sept

3829 Sept

3030 Sept

291 Oct

142 Oct

03 Oct

Expansion▲

Granules India incorporates wholly owned subsidiary in Brazil

Granules India incorporated Triton Farmaceutica Do Brasil Ltda as a wholly owned subsidiary in Brazil
The subsidiary will manufacture, promote, sell and distribute pharmaceuticals and related products in Brazil
Brazil expansion gives Granules India a new market for its pharmaceutical business

Granules India Brazil Pharma and healthcare1 source · 5h

Expansion●

Global Health expands Delhi-NCR footprint with upcoming Medanta hospital in Ghaziabad- details inside

Global Health acquired land in Ghaziabad for a planned Medanta hospital
Expansion may benefit Indian hospital operators competing in Delhi-NCR

Global Health Delhi-NCR Hospitals Pharma and healthcare1 source · 6h

Expansion▲

New launches, chronic portfolio to maintain growth for Zydus Lifesciences

Domestic formulations, chronic therapies and US launches have supported Zydus Lifesciences’ growth and rally
Valuations now stand above…
Growth supports Zydus Lifesciences, though elevated valuations may limit further gains

Zydus Lifesciences Pharma and healthcare Market valuations1 source · 12h

That’s everything for today